Skip to main content

Metronidazole

NDC 50111-333 · Teva Pharmaceuticals USA, Inc.

Generic nameMetronidazole
Dosage formTABLET
RouteORAL
Active ingredient(s)METRONIDAZOLE
Strength250 mg/1
Pharmacologic classNitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
Marketing categoryANDA

Packages

50111-333-01 — 100 TABLET in 1 BOTTLE (50111-333-01)

50111-333-02 — 500 TABLET in 1 BOTTLE (50111-333-02)

50111-333-06 — 250 TABLET in 1 BOTTLE (50111-333-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49884-151 — Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride, 50090-0201 — Metronidazole, 50090-0211 — Metronidazole, 50090-0212 — Metronidazole, 50090-0213 — Metronidazole, 50090-2126 — metronidazole, 50090-4809 — metronidazole, 50090-5691 — Metronidazole, 50090-7160 — Metronidazole, 50090-7345 — Metronidazole, 50111-334 — Metronidazole, 50268-534 — Metronidazole, 50268-535 — Metronidazole, 50742-283 — Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride, 51407-372 — metronidazole, 51407-376 — metronidazole, 51655-441 — METRONIDAZOLE, 51655-974 — METRONIDAZOLE, 51672-4116 — metronidazole, 51672-4164 — Metronidazole, +161 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources